The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment(Retrospective Research)

NCT ID: NCT04291274

Last Updated: 2021-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-01

Study Completion Date

2019-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The long-term effect of general anesthesia on developing brain is the focus of clinicians when infants exposed to general anesthesia for a long time during operation. A retrospective study showed that children exposed to long-term or repeated operations, the anesthetics had a higher incidence of cognitive impairment in adolescence than those did no. When infants with hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators intend to observe the long-term behavioral abnormalities of hearing-impaired infants after intravenous or inhalation anesthesia by a ambispective cohort study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gesell development scale contains five subscales including adaptability, fine motor, gross motor, language, and social skill evaluation. Developmental quotient (DQ) = (development age/actual age)×100. Total DQ is the average of five DQ of subscales. DQ≥86 is normal, 76≤DQ≤85 is suspicious, 55≤DQ≤75 is mild neurological damage, 40≤DQ ≤54 is moderate neurological damage, 25 B DQ B 39 is severe neurological damage, and DQ\< 25 is very severe neurological damage.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Long Term Neurobehavioral Effects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inhalation anesthesia group

Unilateral and Bilateral cochlear implantation,which used inhalation anesthesia

No interventions assigned to this group

intravenous anesthesia group

Unilateral and Bilateral cochlear implantation, which used intravenous anesthesia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children undergoing cochlear implantation under general anesthesia
* 6 to 36-month-old child
* Normal body weight
* Children with normal structures of the inner ear and auditory nerve
* Children without contraindications to anesthesia and surgery
* Patients who have not participated in other clinical trials
* Without any acute infectious diseases or systematic diseases

Exclusion Criteria

* The participants with a Gesell score (fine motor and gross motor) lower than 86 after preoperative evaluation.
* With other illness which could affects curative effect of recovery, such as inner ear malformations (except for large vestibular aqueduct syndrome), auditory vestibular nerve dysplasia, dysgnosia and mental disease;
* Inability to cooperate with the hearing evaluation and the language training
* Cute and chronic otitis media and mastoiditis, unhealed tympanic membrane perforation
* Abnormal structure of brain, including white matter dysplasia, Demyelinating Diseases
Minimum Eligible Age

6 Months

Maximum Eligible Age

36 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jingjie Li

associate chief physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jingjie Li, M.D

Role: STUDY_CHAIR

Shanghai No.9 People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai ninth people's hospital

Shanghai, , China

Site Status

Shanghai No.9 People's Hospital

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Zhang L, Cheng Y, Xue Z, Li J, Wu N, Yan J, Wang J, Wang C, Chen W, Zhou T, Qiu Z, Jiang H. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits. Cell Biol Toxicol. 2022 Apr;38(2):347-369. doi: 10.1007/s10565-021-09601-4. Epub 2021 Apr 29.

Reference Type DERIVED
PMID: 33928466 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SH9H-2019-T293-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anaesthesia and Apoptosis
NCT04431505 UNKNOWN